Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ANGO
#2548
AngioDynamics, Inc.
11.440
0
+1.33%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+1.33%
Aylık değişim
+12.16%
6 aylık değişim
-7.59%
Yıllık değişim
-7.59%
Önceki kapanış
11.290
0
Open
11.440
0
Bid
Ask
Low
11.440
0
High
11.440
0
Hacim
48
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ANGO
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
38.44 M
38.97 M
39.67 M
40.28 M
40.63 M
—
Valuation ratios
Enterprise value
854.89 M
736.16 M
330.67 M
178.09 M
338.26 M
1.56 B
Price to earnings ratio
-28.65
-28.87
-7.11
-1.37
-11.69
-53.47
Price to sales ratio
3.09
2.42
1.1
0.83
1.35
5.84
Price to cash flow ratio
37.38
-106.44
4 788.26
-9
-39.13
-206.07
Price to book ratio
2.05
1.8
0.99
1.23
2.17
3.97
Enterprise value to EBITDA ratio
-74.45
-536.95
-16.15
-0.81
-20.94
-87.57
Profitability ratios
Return on assets %
0.06
0.05
0.1
0.58
0.12
0.1
Return on equity %
0.07
0.06
0.14
0.9
0.19
0.15
Return on invested capital %
26.01
27.59
48.12
273.77
100.56
78.77
Gross margin %
53.88
52.41
51.44
50.9
53.92
218.3
Operating margin %
12.12
9
15.11
63.32
13.66
42.86
EBITDA margin %
-3.95
-0.43
-6.05
-72.14
-5.52
-19.56
Net margin %
10.84
8.4
15.48
60.66
11.62
36.06
Liquidity ratios
Quick ratio
1.6
1.24
1.29
1.46
1.4
5.51
Current ratio
2.45
1.93
1.95
2.12
2.21
8.95
Inventory turnover
2.47
3.01
3.08
2.57
2.2
2.21
Asset turnover
0.5
0.57
0.62
0.71
0.98
1.11
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.04
0.05
0.09
0
—
—
Long term debt to total equity ratio
0.05
0.06
0.13
0
—
—
Per share metrics
Operating cash flow per share
0.63
0.18
0
0.7
0.25
0.14
EBIT per share
-0.92
-0.73
-1.3
-6.15
-0.98
-0.79
EBITDA per share
-0.3
-0.04
-0.52
-5.46
-0.4
-0.35
Total debt per share
—
—
—
—
—
—
Cash per share
1.26
0.74
1.13
1.89
1.37
4.41
Net current asset value per share
3.67
3.67
4.14
4.81
4.12
16.03
Tangible book value per share
1.8
1.82
2.73
3.19
2.79
10.92
Working capital per share
2.17
1.77
2.02
2.54
2.26
8.86
Book value per share
11.46
10.88
9.58
5.12
4.48
17.62
Haberler
Clover Health Q4 Earnings Meet Estimates, Sales Beat, Membership Rises
XRAY Stock Gains Despite Q4 Earnings Miss on Restructuring Initiative
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
ANGO Expands NanoKnife in Europe for Multi-Organ Tumor Ablation
AngioDynamics, NanoKnife sisteminin Avrupa’daki endikasyonlarını genişletiyor
AngioDynamics expands European indications for NanoKnife system
Here's How Veracyte Stock Is Placed Ahead of Q4 Earnings
Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect?
AngioDynamics (ANGO) Down 3.9% Since Last Earnings Report: Can It Rebound?
Here's Why You Should Add Masimo Stock to Your Portfolio Now